Implanet SA engages in manufacturing implants designed for orthopedic surgery. Its products include Madison, Jazz Passer, Lock, Frame and ISS-JAZZ Screw System. The company was founded on January 23, 2007 and is headquartered in Martillac, France.
The current price of ALIMP is 0.0708 EUR — it has decreased by 0.56% in the past 24 hours. Watch IMPLANET stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange IMPLANET stocks are traded under the ticker ALIMP.
ALIMP stock is 4.84% volatile and has beta coefficient of 0.83. Track IMPLANET stock price on the chart and check out the list of the most volatile stocks — is IMPLANET there?
Yes, you can track IMPLANET financials in yearly and quarterly reports right on TradingView.
ALIMP stock has fallen by 2.75% compared to the previous week, the month change is a 3.21% rise, over the last year IMPLANET has showed a 60.62% decrease.
ALIMP net income for the last quarter is −4.41 M EUR, while the quarter before that showed −2.27 M EUR of net income which accounts for −94.10% change. Track more IMPLANET financial stats to get the full picture.
Today IMPLANET has the market capitalization of 8.90 M, it has increased by 2.53% over the last week.
No, ALIMP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALIMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMPLANET stock right from TradingView charts — choose your broker and connect to your account.
ALIMP reached its all-time high on Sep 19, 2017 with the price of 30.8000 EUR, and its all-time low was 0.0350 EUR and was reached on Dec 6, 2023. View more price dynamics on ALIMP chart. See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMPLANET technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMPLANET stock shows the sell signal. See more of IMPLANET technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMPLANET EBITDA is −4.85 M EUR, and current EBITDA margin is −65.13%. See more stats in IMPLANET financial statements.